Havas Health named Anna Maria Marra as CEO of Europe on Tuesday morning, a role in which she will lead and oversee all ...

Havas Health has appointed Anna Maria Marra as CEO of Europe to lead and oversee all aspects of the region's business ...

Pfizer hired Marra all the way back in 2002, at which time the new Havas Health exec had spent a few years working at Merck ...

MAPS 2025 Americas Annual Meeting Annual meeting sessions aligned with MAPS Medical Affairs Competencies Framework provide training oppo ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower ...

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab). In ...

Last night Ward6 picked up another trophy at this year’s PRIME Awards. The agency won Launch of the Year for The PRIME Awards ...

Organon's OGN short percent of float has risen 28.4% since its last report. The company recently reported that it has 12.53 ...

They made the remarks as the international exchange platform, in its seventh edition this year, has attracted many leading ...

International Assets Investment Management LLC increased its holdings in Organon & Co. (NYSE:OGN – Free Report) by 1,851.8% in the third quarter, HoldingsChannel.com reports. The institutional ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...